Ch. 1. Postprandial lipaemia Ch. 2. HDL: are there any benefits in raising it? Ch. 3. The PPAR system and regulation of lipoprotein metabolism Ch. 4. Genetics: determinants of lipid and lipoprotein concentrations Ch. 5. Lipoproteins in the brain: a new frontier? Ch. 6. Familial hypercholesterolaemia Ch. 7. Fibrinogen: an independent coronary heart disease risk factor Ch. 8. Elevated plasma homocysteine: a modifiable risk factor? Ch. 9. Chronic infection and coronary heart disease: potential for new therapies? Ch. 10. Lipids and non-coronary vascular disease Ch. 11. Implications of high lipid levels in the hypertensive patient Ch. 12. Lipids in heart transplant patients Ch. 13. Diabetes, lipids and coronary heart disease: what have we learnt from lipid-lowering trials? Ch. 14. Lowering cardiovascular risk by cholesterol reduction: evidence from observational studies and randomized trials Ch. 15. Women and coronary heart disease: lipid risk factors Ch. 16. An update on the statins Ch. 17. Is there still a place for the fibrates? Ch. 18. New guidelines for the prevention of coronary heart disease.
Includes bibliographical references and index.
Acquired for the Penn Libraries with assistance from the Frances Houston Medical Book Fund.